Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference
Integra LifeSciences (Nasdaq:IART) announced that Bob Davis, executive vice president and president Tissue Reconstruction, will present at the 2026 Truist Securities MedTech Conference on June 16, 2026, at 3:00pm ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Integra LifeSciences (Nasdaq:IART) announced that Bob Davis, executive vice president and president Tissue Reconstruction, will present at the 2026 Truist Securities MedTech Conference on June 16, 2026, at 3:00pm ET.
A live webcast of the presentation will be available on the company’s investor relations website under Events & Presentations.
Details
News Market Reaction – IART
On Jun 15, the day this news came out, IART closed 1.74% below the previous close.
Data tracked by StockTitan Argus for the Jun 15 session.
Key Figures
- Conference date
- June 16, 2026
- Truist Securities MedTech Conference presentation
- Presentation time
- 3:00pm ET
- Scheduled start time for conference remarks
- Share price
- $17.77
- Price before Truist MedTech conference news
- Daily change
- 1.48%
- 24-hour price change prior to article
- 52-week high
- $18.05
- Upper end of 52-week trading range
- 52-week low
- $8.70
- Lower end of 52-week trading range
- Today’s volume
- 533,993 shares
- Trading volume before/around the news
- 20-day avg volume
- 913,217 shares
- Recent average trading activity
Historical Context
-
Jefferies Global Healthcare Conference presentation with live webcast access.
-
BofA Securities 2026 Health Care Conference investor presentation announcement.
-
Appointment of Stuart Essig as CEO and Michael McBreen as chief commercial officer.
-
Q1 2026 results with adjusted EPS guidance raised and revenue guidance reaffirmed.
-
Announcement of timing and access details for Q1 2026 earnings call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Bob Davis, executive vice president and president Tissue Reconstruction will present at the 2026 Truist Securities MedTech Conference on June 16, 2026 at 3:00pm ET.
A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.
About Integra LifeSciences
Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies are trusted by healthcare professionals to deliver life-saving care. For our latest news and information, visit www.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
Integra LifeSciences Holdings Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.